Peregrine Asset Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,522
| Closed | -$216K | – | 173 |
|
|
2023
Q3 | $216K | Buy |
+6,522
| New | +$231K | 0.11% | 137 |
|
|
2022
Q3 | – | Sell |
-9,190
| Closed | -$482K | – | 79 |
|
|
2022
Q2 | $482K | Sell |
9,190
-47,546
| -84% | -$2.42M | 0.35% | 44 |
|
|
2022
Q1 | $2.94M | Sell |
56,736
-63,841
| -53% | -$3.31M | 1.5% | 27 |
|
|
2021
Q4 | $7.12M | Buy |
120,577
+1,125
| +0.9% | +$55.7K | 2.9% | 6 |
|
|
2021
Q3 | $5.14M | Buy |
119,452
+5,939
| +5% | +$263K | 2.62% | 9 |
|
|
2021
Q2 | $4.45M | Sell |
113,513
-134
| -0.1% | -$5.21K | 2.02% | 15 |
|
|
2021
Q1 | $4.12M | Sell |
113,647
-4,218
| -4% | -$150K | 2.1% | 16 |
|
|
2020
Q4 | $4.34M | Sell |
117,865
-8,131
| -6% | -$298K | 2.03% | 13 |
|
|
2020
Q3 | $4.39M | Buy |
125,996
+100,250
| +389% | +$3.51M | 2.41% | 12 |
|
|
2020
Q2 | $799K | Buy |
25,746
+18,836
| +273% | +$640K | 0.45% | 44 |
|
|
2020
Q1 | $214K | Buy |
6,910
+31
| +0.5% | +$1.06K | 0.16% | 77 |
|
|
2019
Q4 | $256 | Sell |
6,879
-373
| -5% | -$13.3K | 0.06% | 93 |
|
|
2019
Q3 | $247K | Buy |
7,252
+32
| +0.4% | +$1.16K | 0.14% | 84 |
|
|
2019
Q2 | $297K | Buy |
7,220
+28
| +0.4% | +$1.11K | 0.15% | 90 |
|
|
2019
Q1 | $290K | Buy |
7,192
+25
| +0.3% | +$1K | 0.17% | 85 |
|
|
2018
Q4 | $297K | Sell |
7,167
-178
| -2% | -$7.39K | 0.39% | 53 |
|
|
2018
Q3 | $307K | Buy |
7,345
+226
| +3% | +$8.7K | 0.14% | 89 |
|
|
2018
Q2 | $245K | Buy |
7,119
+29
| +0.4% | +$991 | 0.13% | 95 |
|
|
2018
Q1 | $239K | Buy |
7,090
+28
| +0.4% | +$963 | 0.16% | 86 |
|
|
2017
Q4 | $243K | Buy |
7,062
+27
| +0.4% | +$921 | 0.12% | 89 |
|
|
2017
Q3 | $238K | Sell |
7,035
-716
| -9% | -$23K | 0.13% | 77 |
|
|
2017
Q2 | $247K | Buy |
7,751
+37
| +0.5% | +$1.17K | 0.16% | 70 |
|
|
2017
Q1 | $250K | Buy |
7,714
+34
| +0.4% | +$1.07K | 0.13% | 73 |
|
|
2016
Q4 | $237K | Buy |
7,680
+34
| +0.4% | +$1.04K | 0.14% | 90 |
|
|
2016
Q3 | $246K | Buy |
7,646
+31
| +0.4% | +$1.04K | 0.15% | 90 |
|
|
2016
Q2 | $254K | Buy |
7,615
+30
| +0.4% | +$957 | 0.17% | 87 |
|
|
2016
Q1 | $213K | Sell |
7,585
-218
| -3% | -$6.23K | 0.16% | 93 |
|
|
2015
Q4 | $239K | Sell |
7,803
-1,479
| -16% | -$46.5K | 0.21% | 77 |
|
|
2015
Q3 | $277K | Buy |
9,282
+30
| +0.3% | +$962 | 0.28% | 65 |
|
|
2015
Q2 | $294K | Sell |
9,252
-95
| -1% | -$3.1K | 0.22% | 77 |
|
|
2015
Q1 | $309K | Buy |
9,347
+1,538
| +20% | +$48.9K | 0.2% | 89 |
|
|
2014
Q4 | $231K | Buy |
7,809
+29
| +0.4% | +$832 | 0.16% | 102 |
|
|
2014
Q3 | $218K | Sell |
7,780
-247
| -3% | -$6.93K | 0.18% | 98 |
|
|
2014
Q2 | $226K | Buy |
8,027
+28
| +0.4% | +$798 | 0.2% | 99 |
|
|
2014
Q1 | $244K | Buy |
7,999
+28
| +0.4% | +$835 | 0.19% | 93 |
|
|
2013
Q4 | $232K | Buy |
7,971
+24
| +0.3% | +$698 | 0.2% | 94 |
|
|
2013
Q3 | $217K | Buy |
7,947
+27
| +0.3% | +$735 | 0.21% | 127 |
|
|
2013
Q2 | $210K | Buy |
+7,920
| New | +$219K | 0.22% | 118 |
|
Other funds holding PFE
